Alpha Cognition Inc ACOGF

$ACOG study shows that their A-1062 drug helps with TBI

[StockHawk1]

As boomers begin to enter old age more and more of the population will be elderly. This fundamental change in the makeup of our population should be kept in mind when making long-term investments and is one of the reasons why Alpha Cognition ( $ACOG.V $ACOGF ) is one of my picks.

Almost 6% of people 75-80 and diagnosed with dementia (including Alzheimer's) that number jumps up to about 12% from 80-85 and almost a quarter of people 85+ are affected.There already is a huge demand for dementia and Alzheimer's treatment and that demand will only be growing as boomers age. (source: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/dementia-highlights-canadian-chronic-disease-surveillance.html)

$ACOG is a biopharmaceutical company that is developing new medication for neurodegenerative disorders like Alzheimer's and ALS.

Today the company announced that their ALPHA-1062 drug (which has been shown to help with the effects of Alzheimer's) was found to help with traumatic brain injury, reducing the extent of functional deficits, and improved functional recovery of animals with brain injuries.

In most functional measures of recovery, the animals treated with ALPHA-1062 were statistically indistinguishable from uninjured animals.

This study really displays the power of their ALPHA-1062 drug, and these results are great for stakeholders to hear.

$ACOG at just $0.98, MC $62.11M

https://finance.yahoo.com/news/alpha-cognition-announce-data-pre-140000753.html

[ferret_ca]

I see the market is just thrilled with this announcement, lol.  someone wanted out, big drop for not much volume, lets see if any insiders step in and buy any down here.